marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-12-2024
TherapeuticsMD Cash Flow 2011-2024 | TXMD
Annual Cash Flow TherapeuticsMD
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | -159 M | -166 M | -107 M | -76.2 M | -69.1 M | -79 M | -45.5 M | -20.8 M | -12.7 M | -4.97 M |
Depreciation & Amortization |
922 K | 1.19 M | 736 K | 4.07 M | 1.39 M | 294 K | 213 K | 132 K | 62.4 K | 52.5 K | 58.1 K | 56.3 K | 54.8 K |
Accounts Payables |
27 K | 2.16 M | 3.37 M | 21.1 M | 19.2 M | 22.7 M | 4.1 M | 7.36 M | 3.13 M | 6.33 M | 2.11 M | 1.64 M | 307 K |
Accounts Receivables |
- | - | - | 32.4 M | 24.4 M | 11.1 M | 4.33 M | 4.5 M | 3.05 M | 2.15 M | 1.69 M | 607 K | 26.7 K |
Total Inventories |
- | - | - | 7.99 M | 11.9 M | 3.27 M | 1.49 M | 1.08 M | 690 K | 1.18 M | 1.04 M | 1.62 M | 588 K |
All numbers in USD currency
Quarterly Cash Flow TherapeuticsMD
| 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | -8.7 M | - | -63.8 M | -44.9 M | -17.9 M | - | -103 M | -64.9 M | -38.4 M | - | -129 M | -95.1 M | -39.1 M | - | -115 M | -88.7 M | -38.2 M | - | -78.7 M | -44.6 M | -19.6 M | - | -55.4 M | -38.7 M | -20.5 M | - | -53.5 M | -34.7 M | -19.4 M | - | -62.4 M | -44 M | -19.1 M | - | -30.2 M | -18.8 M | -8.71 M | - | -16 M | -10.7 M | -3.51 M | - | -8.73 M | -5.65 M | -2.45 M | - | -3.08 M | -1.56 M | -761 K |
Depreciation & Amortization |
180 K | - | - | 128 K | 27 K | - | 200 K | 200 K | 329 K | - | 3.09 M | 2.06 M | 1.02 M | - | 259 K | 257 K | 1.01 M | - | 142 K | 115 K | 107 K | - | 73.3 K | 65.6 K | 59.6 K | - | 54.1 K | 53.2 K | 49.7 K | - | 40.5 K | 24.3 K | 19.6 K | - | 16.5 K | 14.3 K | 13.6 K | - | 12.7 K | 14.1 K | 13.1 K | - | 32.4 K | 10.6 K | 7.96 K | 28.8 K | 14.8 K | 14.5 K | 14.6 K | - | 41.1 K | 27.4 K | 13.7 K |
Accounts Payables |
143 K | 27 K | 696 K | 1.51 M | 2.33 M | 2.16 M | 13.4 M | 14 M | 20.8 M | 20.3 M | 19.6 M | 14.6 M | 10.3 M | 21.1 M | 21.1 M | 21.1 M | 21.1 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 22.7 M | 22.7 M | 22.7 M | 22.7 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 7.36 M | 7.36 M | 7.36 M | 7.36 M | 3.13 M | 3.13 M | 3.13 M | 3.13 M | 6.33 M | 6.33 M | 6.33 M | 6.33 M | 2.11 M | 2.11 M | 2.11 M | 2.11 M | 1.64 M | 1.64 M | 1.64 M | 1.64 M | 307 K | 307 K | 307 K | 307 K |
Accounts Receivables |
- | - | - | - | - | - | 32.2 M | 45.8 M | 35.4 M | 36.2 M | 37.4 M | 33.5 M | 33.7 M | 32.4 M | 32.4 M | 32.4 M | 32.4 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 4.33 M | 4.33 M | 4.33 M | 4.33 M | 4.5 M | 4.5 M | 4.5 M | 4.5 M | 3.05 M | 3.05 M | 3.05 M | 3.05 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M | 714 K | 607 K | 607 K | 607 K | 26.7 K | 26.7 K | 26.7 K | 26.7 K |
Total Inventories |
- | - | - | - | - | - | 6.7 M | 6.15 M | 8.97 M | 7.62 M | 7.36 M | 7.57 M | 7.35 M | 7.99 M | 7.99 M | 7.99 M | 7.99 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 3.27 M | 3.27 M | 3.27 M | 3.27 M | 1.49 M | 1.49 M | 1.49 M | 1.49 M | 1.08 M | 1.08 M | 1.08 M | 1.08 M | 690 K | 690 K | 690 K | 690 K | 1.18 M | 1.18 M | 1.18 M | 1.18 M | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 588 K | 588 K | 588 K | 588 K |
All numbers in USD currency